Citius Oncology, Inc. (CTOR)
0.9009
-0.01
(-0.92%)
USD |
NASDAQ |
May 07, 16:00
0.8821
-0.02
(-2.09%)
Pre-Market: 08:59
Citius Oncology EPS Diluted (Quarterly) : -0.0633 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | -0.3824 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.534M |
| Revenue (Quarterly) | 3.944M |
| Total Expenses (Quarterly) | 9.478M |
| Enterprise Value | 76.03M |
| Gross Profit Margin (Quarterly) | 79.99% |
| Profit Margin (Quarterly) | -140.3% |
| Earnings Yield | -34.20% |
| Normalized Earnings Yield | -34.21 |